Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma

This study retrospectively compared nedaplatin and irinotecan hydrochloride (NDP/CPT) combination therapy with cisplatin and irinotecan hydrochloride therapy (CDDP/CPT) for efficacy and adverse events in the treatment of clear cell adenocarcinoma of the ovary (CCC) and recurrent ovarian carcinoma. A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: MACHIDA, SHIZUO, SATO, TOMOMI, FUJIWARA, HIROYUKI, SAGA, YASUSHI, TAKEI, YUJI, TANEICHI, AKIYO, NONAKA, HIROAKI, SUZUKI, MITSUAKI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3499502/
https://ncbi.nlm.nih.gov/pubmed/23162643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados